Open AccessCardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management
Author(s) -
Hemal Shroff,
Lisa B. VanWagner
Publication year - 2020
Publication title -
current hepatology reports
Language(s) - English
Resource type - Journals
ISSN - 2195-9595
DOI - 10.1007/s11901-020-00530-0
Subject(s) - medicine , intensive care medicine , steatohepatitis , nonalcoholic steatohepatitis , disease , metabolic syndrome , nonalcoholic fatty liver disease , steatosis , clinical trial , fatty liver , obesity
The global burden of non-alcoholic steatohepatitis (NASH) as a major cause of chronic liver disease continues to rise. Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in this patient population. The current review summarizes recent advances in the understanding of CVD in NASH and strategies for screening and management.